Kevin Bowrin
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 10
-
- Atrial Fibrillation Management and Outcomes 14
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Cardiac Arrhythmias and Treatments 6
-
- Peripheral Artery Disease Management 7
- Coronary Interventions and Diagnostics 3
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life 12
- Pharmaceutical Economics and Policy 4
- Co-authors
- J BrièreMaria HuelsebeckRupert BauersachsUwe ZeymerC. MarreMondher ToumiA. MillierCraig I Coleman
- Journals
- Journal of Medical Economics (7 papers)Current Medical Research and Opinion (4 papers)Cardiovascular Therapeutics (4 papers)
- Partner nations
- GermanyUnited KingdomFrance
In The Last Decade
Kevin Bowrin
27 papers receiving 587 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Internal Medicine 97
- Cardiology and Cardiovascular Medicine 309
- Surgery 172
- Family Practice 8
- Economics and Econometrics 83
Countries citing papers authored by Kevin Bowrin
This map shows the geographic impact of Kevin Bowrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Bowrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Bowrin more than expected).
Fields of papers citing papers by Kevin Bowrin
This network shows the impact of papers produced by Kevin Bowrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Bowrin. The network helps show where Kevin Bowrin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin Bowrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 7 | |
| 11 | 2019 | 0 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 30 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 44 | |
| 17 | 2018 | 27 | |
| 18 | 2017 | 8 | |
| 19 | Abstract 17731: Persistence With Non-vitamin K Oral Anticoagulants And Vitamin K Antagonists Treatment: A Nationwide Study Of Danish Patients With Non-Valvular Atrial Fibrillation | 2016 | 1 |
| 20 | 2016 | 1 |
About Kevin Bowrin
Kevin Bowrin is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Economics and Econometrics, Statistics, Probability and Uncertainty and Pharmacology, having authored 28 papers that have together received 599 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Peripheral Artery Disease Management (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Cardiac Arrhythmias and Treatments (6 papers), Pharmaceutical Economics and Policy (4 papers) and Coronary Interventions and Diagnostics (3 papers). The work is most often cited by research in Internal Medicine (97 citations), Cardiology and Cardiovascular Medicine (309 citations), Surgery (172 citations), Family Practice (8 citations) and Economics and Econometrics (83 citations). Kevin Bowrin has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include J Brière, Maria Huelsebeck, Rupert Bauersachs, Uwe Zeymer, C. Marre, Mondher Toumi, A. Millier, Craig I Coleman, Pierre Lévy and V. Taieb. Their work appears in journals such as Journal of Medical Economics, Current Medical Research and Opinion, Cardiovascular Therapeutics, PLoS ONE and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.